Filing Details

Accession Number:
0001927062-22-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-15 18:05:47
Reporting Period:
2022-12-13
Accepted Time:
2022-12-15 18:05:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374339 Promis Neurosciences Inc. PMN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1927062 D. Patrick Kirwin C/O Promis Neurosciences Inc.
Suite 200, 1920 Yonge Street
Toronto A6 M4S 3E2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-12-13 1,000 $4.87 25,998 No 4 P Indirect By Patrick D. Kirwin Professional Corp
Common Shares Acquisiton 2022-12-15 2,000 $4.51 27,998 No 4 P Indirect By Patrick D. Kirwin Professional Corp
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Patrick D. Kirwin Professional Corp
No 4 P Indirect By Patrick D. Kirwin Professional Corp
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 41,983 Direct
Common Shares 2,383 Indirect By Patrick Kirwin TFSA
Common Shares 5,732 Indirect By his spouse
Footnotes
  1. The purchase price of CAD$6.60 has been converted to USD based on the WSJ exchange rate on December 13, 2022 of CAD$1.00=US$0.7383
  2. The purchase price of CAD$6.16 has been converted to USD based on the WSJ exchange rate on December 15, 2022 of CAD$1.00=US$0.7322